United States

UnitedHealth Group's Database of Medical Prices Declared Flawed, New Group to be Developed

UnitedHealth Group's Database of Medical Prices Declared Flawed, New Group to be

In a recent announcement by Andrew Cuomo, New York's Attorney General, he expressed the need for a new database of medical prices. Calling the current version maintained by the UnitedHealth Group "flawed", he urged FAIR Health Inc., a new not-for-profit company, and a group of New York Universities to join hands and develop and maintain a new national database.

Accelerated FDA Approval for GSK and Genmab's Arzerra

Arzerra, a leukemia treatment for patients who have either stopped responding or have altogether failed to respond to other treatments and therapies, has received accelerated approval by the Food and Drug Administration as of Monday. The treatment will be marketed by GlaxoSmithKline PLC.

IBD Patients are More Prone to Skin Cancer

The inflammatory bowel disease (IBD), figured by a group of inflammatory conditions of the colon and small intestine, may built a high risk of skin cancer among the patients. The major types of IBD are Crohn's disease and ulcerative colitis. 

Capmark Financial Group Files for Bankruptcy over $21 Billion Debt


Post a second quarter loss of nearly $1.6 Billion, and a debt figure which now stands firm at $21 Billion, Capmark Financial Group Inc., has now filed for bankruptcy as per the firm's filing of Chapter 11 documents in the US Bankruptcy Court in Wilmington, Delaware. The company revealed consolidated debts of $21 Billion in contrast to consolidated assets of $20.1 Billion as of the estimates of June 30.

Merlin Entertainment to Go Public in 2010 - Financial Times

As reported by the Financial Times website on Friday, theme park group owner of Legoland and the London Eye, Merlin Entertainment is planning to go public as of 2010. Expected anytime early next year, Blackstone Group's giant Merlin Entertainment would be valued at an approximate 2 Billion British Pounds ($3.26 Billion), and the offering will on the London Stock Exchange.

Gene Therapy Particularly Effective in Treating Inherited Sight Problems in Children - Study

A recent study conducted by researchers in Pennsylvania has shown that Gene Therapy can be highly effective in treating inherited sight defects in children. The study, which takes its cue from a similar research done by doctors at the Moorfields Eye Hospital in London, reported that US doctors were able to significantly improve children' visions which had been marred by a rare genetic eye disorder. Doctors were treating 12 patients in all, and the youngest ones responded really well to the therapy.